XINGANJIANG
873167
INNOVATIVE DATA
835305
CHENGUANG MEDICAL
430300
4
Hangzhou Gaoxin Materials Technology
300478
5
Beijing Philisense Technology
300287
(FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | |
---|---|---|---|---|---|---|---|---|---|---|
Total revenue | 13.54%394.19M | 18.34%106.93M | 17.66%102.67M | 11.53%96.09M | 6.10%88.5M | 17.62%347.18M | 19.63%90.36M | 10.95%87.26M | 21.90%86.15M | 18.62%83.41M |
Operating revenue | 13.54%394.19M | 18.34%106.93M | 17.66%102.67M | 11.53%96.09M | 6.10%88.5M | 17.62%347.18M | 19.63%90.36M | 10.95%87.26M | 21.90%86.15M | 18.62%83.41M |
Cost of revenue | 13.21%257.34M | 18.98%70.55M | 18.86%67.73M | 12.24%62.63M | 2.17%56.43M | 12.47%227.31M | 16.27%59.3M | 12.04%56.99M | 13.25%55.8M | 8.34%55.23M |
Gross profit | 14.17%136.85M | 17.12%36.38M | 15.41%34.94M | 10.23%33.46M | 13.81%32.07M | 28.80%119.87M | 26.62%31.06M | 8.95%30.27M | 41.81%30.36M | 45.71%28.18M |
Operating expense | -1.65%95.05M | 2.00%26.58M | -12.91%20.31M | -6.80%22.19M | 10.71%25.97M | -3.14%96.64M | -25.34%26.06M | 3.40%23.32M | 9.57%23.81M | 13.90%23.46M |
Selling and administrative expenses | -8.44%58.94M | -3.17%16.45M | -27.14%11.56M | -13.71%13.8M | 10.34%17.12M | -8.16%64.37M | -36.66%16.99M | 4.14%15.87M | 12.63%16M | 12.22%15.52M |
-Selling and marketing expense | 10.20%44.72M | 5.06%11.08M | 8.07%10.87M | 17.69%11.51M | 10.45%11.26M | 13.36%40.58M | 17.18%10.54M | 16.11%10.06M | 4.44%9.78M | 16.23%10.2M |
-General and administrative expense | -40.23%14.22M | -16.62%5.37M | -88.15%688K | -63.09%2.3M | 10.12%5.86M | -30.62%23.79M | -63.84%6.45M | -11.64%5.81M | 28.47%6.22M | 5.26%5.32M |
Research and development costs | 8.29%34.95M | -1.11%8.97M | 17.39%8.75M | 7.33%8.39M | 11.45%8.85M | 8.70%32.27M | 12.25%9.07M | 1.86%7.45M | 3.79%7.81M | 17.34%7.94M |
Other operating expenses | --1.16M | --1.16M | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
Operating profit | 79.99%41.8M | 95.88%9.8M | 110.37%14.63M | 72.16%11.27M | 29.23%6.1M | 445.76%23.23M | 148.25%5M | 32.83%6.96M | 2,127.24%6.55M | 475.04%4.72M |
Net non-operating interest income expense | -48.72%-11.47M | -83.58%-4.86M | -6.50%-1.83M | -1.59%-1.92M | -96.23%-2.86M | -57.16%-7.72M | -64.02%-2.65M | 3.15%-1.72M | -149.14%-1.89M | -92.09%-1.46M |
Non-operating interest income | ---- | ---- | ---- | ---- | ---- | -13.08%93K | ---- | ---- | ---- | ---- |
Non-operating interest expense | 52.22%11.47M | 96.72%4.86M | 6.50%1.83M | 1.59%1.92M | 96.23%2.86M | 50.28%7.54M | 43.55%2.47M | -3.15%1.72M | 149.14%1.89M | 92.09%1.46M |
Total other finance cost | ---- | ---- | ---- | ---- | ---- | --270K | ---- | ---- | ---- | ---- |
Other net income (expense) | -11.13%-3.08M | 82.18%-283K | -2.01%-915K | -1.88M | 50.72%-2.77M | 3.52%-1.59M | 92.87%-283K | -897K | ||
Gain on sale of security | ---- | ---- | ---- | ---- | ---- | 46.10%-753K | ---- | ---- | ---- | ---- |
Special income (charges) | -52.66%-3.08M | 66.11%-283K | --0 | -2.01%-915K | ---1.88M | 52.25%-2.02M | -235.34%-835K | 92.87%-283K | ---897K | --0 |
-Less:Restructuring and merger&acquisition | 52.66%3.08M | -66.11%283K | --0 | 2.01%915K | --1.88M | -52.25%2.02M | 235.34%835K | -92.87%283K | --897K | --0 |
Income before tax | 113.88%27.25M | 507.04%4.66M | 158.53%12.8M | 124.22%8.44M | -58.34%1.36M | 173.90%12.74M | 105.63%767K | 1,064.91%4.95M | 448.61%3.77M | 261.63%3.26M |
Income tax | -51.09%3.19M | -46.90%1.05M | -63.36%580K | -63.69%609K | -26.08%955K | 166.64%6.52M | 42.24%1.97M | 352.29%1.58M | 281.14%1.68M | 376.75%1.29M |
Net income | 286.86%24.06M | 400.08%3.61M | 262.85%12.22M | 275.14%7.83M | -79.52%403K | 131.59%6.22M | 91.99%-1.2M | 490.15%3.37M | 237.37%2.09M | 186.01%1.97M |
Net income continuous Operations | 286.86%24.06M | 400.08%3.61M | 262.85%12.22M | 275.14%7.83M | -79.52%403K | 131.59%6.22M | 91.99%-1.2M | 490.15%3.37M | 237.37%2.09M | 186.01%1.97M |
Minority interest income | ||||||||||
Net income attributable to the parent company | 286.86%24.06M | 400.08%3.61M | 262.85%12.22M | 275.14%7.83M | -79.52%403K | 131.59%6.22M | 91.99%-1.2M | 490.15%3.37M | 237.37%2.09M | 186.01%1.97M |
Preferred stock dividends | ||||||||||
Other preferred stock dividends | ||||||||||
Net income attributable to common stockholders | 286.86%24.06M | 400.08%3.61M | 262.85%12.22M | 275.14%7.83M | -79.52%403K | 131.59%6.22M | 91.99%-1.2M | 490.15%3.37M | 237.37%2.09M | 186.01%1.97M |
Basic earnings per share | 300.00%0.28 | 500.00%0.04 | 250.00%0.14 | 376.44%0.0953 | -76.44%0.0047 | 130.43%0.07 | 66.67%-0.01 | 500.00%0.04 | 200.00%0.02 | 166.67%0.02 |
Diluted earnings per share | 285.71%0.27 | 500.00%0.04 | 250.00%0.14 | 327.00%0.0854 | -77.00%0.0046 | 130.43%0.07 | 66.67%-0.01 | 500.00%0.04 | 200.00%0.02 | 166.67%0.02 |
Dividend per share | ||||||||||
Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
Audit Opinions | -- | -- | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- |